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Caregivers' knowledge about children's paracetamol
Abstract
Although safe, paracetamol, commonly used in children, can cause adverse events if not administered
correctly. This research aimed to investigate caregivers' knowledge about children's paracetamol. A
convenience sample of caregivers who had purchased Children's Panadol were asked to complete an online
survey, assessing their knowledge of paracetamol. Most of the 174 respondents were female (93.7%), highly-
educated (72.4%) with adequate functional health literacy (85.6%). Almost all respondents correctly
identified that Children's Panadol contained paracetamol (96.6%). However, approximately a quarter of them
did not know the maximum daily dose (26.4%), just under half (46%) did not know how many days this dose
could be safely given, and over one-third (37.4%) did not know that liver toxicity could result from overdose.
These findings suggest that adult caregivers administering paracetamol to children have gaps in their
knowledge. Strategies to help improve caregiver's knowledge about the correct and safe administration of
children's paracetamol need to be considered.
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INTRODUCTION 
Paracetamol, or acetaminophen, a medication commonly used to treat pain and fever, is readily 
available worldwide (1). Over-the-counter (OTC) liquid preparations of paracetamol are frequently 
used in children, especially among those aged up to two years (2). If given in accordance to dosage 
recommendations, paracetamol is safe and effective (3). However, if given in doses which exceed 
these recommendations, paracetamol can cause severe adverse effects (4). Notably, paracetamol is 
one of the most common agents of unintentional poisoning in young children (5–8), and is a major 
cause of paediatric acute liver failure (5,9). 
Information about the safe administration of OTC paracetamol products can be obtained from health 
professionals; product packaging and information inserts. This study aimed to investigate if 
Australian adult caregivers have sufficient knowledge to correctly and safely administer 
paracetamol to children. The Children’s Panadol™ brand was specifically chosen because it is a 
well-known and commonly purchased brand. 
Methods 
Following human research ethics approval from the University of Wollongong (HE14/455), a 
cross-sectional online survey was administered via SurveyMonkey between September and October 
2015. The survey included demographic questions (seven items including a health literacy question 
which was assessed using the single item literacy screener (10,11) and product knowledge 
questions required to safely and correctly administer children’s paracetamol (12 items based on 
information available on the product packaging)(Appendix 1). To be able to answer questions 12 
and 13 of the survey, participants were provided with a copy of the dosage information provided on 
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the packaging of Children’s Panadol Elixir 5 -12 years. 
 
A convenience sample of respondents was obtained using Facebook. A link to the online survey 
(Appendix 1) was posted via Facebook to all Facebook friends of the research team. This was then 
followed by a snowball sampling technique, whereby study participants recruited via Facebook 
were encouraged to share the link to the survey with their Facebook friends. A link to the survey was 
also included on three Australian online parenting forums, Raising Children 
(http://raisingchildren.net.au/), BubHub (http://www.bubhub.com.au/index.php) and Essential 
Baby (http://www.essentialbaby.com.au/). 
 
Potential participants were informed that they needed to have purchased one of the following 
products: Children's Panadol® Baby Drops 1 month - 2 years; Children’s Panadol® Suspension 1 - 
5 years; and/or Children’s Panadol® Elixir 5 – 12 years to be eligible to complete the survey. 
 








The 174 respondents were mainly females (n=163, 93.7%) aged between 21 to 68 years 
(mean age = 35.6 ±  SD = 6.65 years). The majority were Australian-born (n= 146, 83.9%) and 
tertiary educated (n=126, 72.4%), with adequate functional health literacy scores (n=149, 85.6%). 
The following is a breakdown of the Panadol™ products purchased by the respondents, some of 
which had bought more than one product: Children's Panadol® Baby Drops 1 month - 2 years 
 
(n=64, 36.8%); Children’s Panadol® Suspension 1 - 5 years (n=74, 42.5%); and Children’s 
Panadol® Elixir 5 – 12 years (n=71, 40.8%). The respondents’ children (who had received the 
Children’s Panadol™) were aged between one-month and 12.6 years (mean age 5 years). The main 
reasons for administering Children’s Panadol™, which was mostly purchased from pharmacies 
(n=172, 98.9%), were fever (n=130, 74.7%) and pain (n=95, 53.4%). 
 
 




Almost all respondents knew that Children’s Panadol™ contained paracetamol (n= 168, 96.6%). 
However, some also believed that the product contained alcohol (n= 36, 20.7%), aspirin (n= 24, 
13.7%), codeine (n= 23, 13.2%) and/or ibuprofen (n= 18, 10.4%). 
 
 
Contraindications and potential side effects 
 
Respondents’ knowledge of contraindications and side effects was variable (Table 1). Prior to 
administering the children’s paracetamol, the majority of respondents (83.3%) knew to check with 
their doctor or pharmacist if their child was taking other medications. Notably however, less than a 
third (30.5%) knew that they did not need to check with their doctor or pharmacist if their child had 
asthma. The respondents’ knowledge about allergies to other medications (e.g. ibuprofen, aspirin) 
or food products (e.g. milk, eggs, gluten) not being a contraindication to paracetamol administration 
was variable; with less knowledge about food products (47.7%-57.5%) than medications (64.4%-
74.1%) (Table 1). 
 
Respondents’ knowledge of the potential side effects caused by paracetamol overdosing was low 
 
(Table 1). While just over 60% of the respondents knew that liver toxicity was a potential side 
effect, approximately one-fifth (21.3%) were unsure of any potential side effects associated with 
giving too much paracetamol. 
 
 
Table 1: Correct responses for possible contraindications or side-effects 
 
Survey Questions Number  
of correct responses 
Percentage 
 
of correct responses 
Should you check with your doctor or pharmacist before giving Children’s Panadol™(correct 
answer in brackets) 
If they have asthma (no) 53 30.5% 
If they are on other medications (yes) 145 83.3% 
If they have heart disease (no) 19 10.9% 
You can give Children’s Panadol™ to children who are… 
Allergic to ibuprofen (yes) 129 74.1% 
Allergic to aspirin (yes) 112 64.4% 
Allergic to milk products (yes) 100 57.5% 
Allergic to eggs (yes) 93 53.4% 
Gluten intolerant (yes) 83 47.7% 
Which of the following side effects might be experienced when given too much Children’s 
Panadol™ 
Liver poisoning (yes) 109 62.6% 
Stomach problems (no) 76 43.7% 
Unsure 37 21.3% 
 
Reading and comprehending dosage instructions: 
 
After being provided with information from a Children’s Panadol® Elixir 5 – 12 years packet, 
participants were asked to identify the correct dosage; a) if their child was 9 years old; and b) if 
 
their child weighed 21 kilograms. The majority of respondents correctly interpreted recommended 
dosage instructions for both scenarios (n=167, 96%; and n=150, 86.2% respectively). However, 
approximately a quarter of the respondents (n=40, 23.0%) did not know that a four hour interval 
was required between doses, and a similar proportion of respondents (n=46, 26.4%) did not know 
that four doses is the maximum number a child should receive within a 24 hour period. 
Furthermore, just under half of the respondents incorrectly believed that Children’s Panadol™ 
could be safely given (without medical advice) for more than two days in a row (n=80, 46%), 
with over one-third incorrectly believing that paracetamol could be safely administered to 





The findings from this study show gaps in respondents’ knowledge regarding the safe 
administration of paracetamol to children, despite being a highly educated sample with high 
functional health literacy. For instance, although the majority knew that paracetamol was the 
active ingredient in Children’s Panadol™, many believed that the product contained other active 
ingredients and that food allergies were contraindications for the administration of paracetamol to 
children. This may inadvertently result in children not receiving paracetamol when it is a safe 
option for the treatment of fever and pain, as was the case for many children included in this 
study. Also, approximately one-quarter of the respondents were not aware of the correct interval 
between doses and did not recognise that four doses is the maximum a child should receive in a 
day. This lack of knowledge may lead to accidental overdosing of the child in their care. What is 
even more concerning is that almost 40% of the respondents did not know that liver toxicity is a 
potential side effect associated with paracetamol overdose. These results are similar to those of 
 
other studies which investigated adults’ knowledge about paracetamol doses and toxicity (12,13). 
 
It could be argued therefore, that even though the majority of respondents in the current study 
purchased their children’s Panadol™ from a pharmacy (where they presumably received 
information about the product), further strategies are required to supplement this information 
channel and address their knowledge gaps. These strategies need to be considered by pharmacists 
working in both community and hospital settings, and could include improved pharmacist-
consumer communication, as well as improved general knowledge about the safe administration 
of paracetamol and potential adverse events associated with overdose. 
 
This study has a number of limitations, which include the use of a self-report survey, possibly 
introducing reporting bias. The sample was relatively small and not reflective of the wider 
population as it was highly educated [86.2% of the sample had a trade or university qualification 
as compared to 43.6% of the population as a whole (14)] and the majority of respondents were 
born in Australia [83.9% in the sample compared to 72.3% for Australia as a whole (15)]. This 
may affect the generalisability of the results to the wider Australian population. It is important 
however, to consider the consequences of adult caregivers who are less educated with low 
functional health literacy, or are not fluent in English, because they may be experiencing even 
bigger gaps in their knowledge about the safe use and administration of paracetamol to the 





Despite being a highly educated sample, our findings suggest caregivers administering children’s 
 
paracetamol have gaps in their product knowledge. This is an important public health concern given 
the ready access to over-the-counter paracetamol products for children. To address these knowledge 
gaps, it is important to consider multiple strategies which could include: improving pharmacist-
consumer communication and general knowledge about paracetamol and potential adverse events 
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1. Which medicine did you buy? 
  Children's Panadol Colour-free Baby Drops 1 month - 2 years 
  Children's Panadol Colour-free Suspension 1 - 5 years 
  Children's Panadol Elixir 5 -12 years 
 
2.  Where did you purchase this medicine? 
  From a pharmacy 
  Online 
  Supermarket 
  Other (please specify)______________________________________ 
 
3. How old is the child and/or children who will be receiving this medicine?  
Age of child 1 ___years ___months 
Age of child 2 ___years ___months 
Age of child 3 ___years ___months 
Age of child 4 ___years ___months 
Age of child 5 ___years ___months 
 
4. Why did you buy this medicine for your baby or child?  
You can tick more than one box if necessary. 
  Teething 
  Ear ache 
  Sore throat 
  Sleep disturbances 
  Temperature (fever) 37.5 degrees or above 
  Pain 
  After vaccination 
  Other (please specify)_______________________________________ 
 
5. What ingredients are in this medicine? Please choose YES, NO or Unsure for each option. 
 Yes No Unsure 
Paracetamol    
Aspirin    
Ibuprofen    
Alcohol    






6. When should you check with your doctor or pharmacist before giving this medicine to  
your baby or child?  Please choose YES, NO or Unsure for each option. 
 Yes No Unsure 
If they have asthma    
If they are on another medicine    
If they have a heart condition    
 
7. Please choose YES, NO or Unsure for each of the following options. 
 Yes No Unsure 
Can you give Panadol to children who are allergic to ibuprofen?    
Can you give Panadol to children who are allergic to aspirin?    
Can you give Panadol to children who are allergic to milk products?    
Can you give Panadol to children who are allergic to eggs?    
Can you give Panadol to children who are gluten intolerant?    
 
8. Which of the following side effects might be experienced by babies or children when  
given too much of this medicine? Please tick as many answers as you think are correct. 
  Liver poisoning 
  Stomach problems 
  Unsure 
 
9. What is the MAXIMUM recommended dose of this medicine that you can give a baby or  
child in one day (24 hour period)? Please tick ONE answer only. 
  2 doses 
  3 doses 
  4 doses 
  6 doses 
  Unsure 
 
10. How many days in a row can you safely give this medicine to a baby or child?  
Please tick ONE answer only. 
  Up to 2 days 
  Up to a week 
  Up to a month 
  Up to 6 months 
  Up to 12 months or longer 
 
11. If you gave a dose of this medicine to a child at 8 am, when is the earliest time that  
another dose can be given on the same day? Please tick ONE answer only. 
 
  At 10.00 am 
  At 12:00 noon 
  At 2.00 pm 
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  At 3:00 pm 
  At 4:00 pm 
 
 
To answer questions 12 and 13 below, please read the information provided in the table below, which is 
also available on the packaging for Children's Panadol Elixir 5 years – 12 years. 
 
Age Average Weight Dose 
5-6 years 18-20 kg 6 mL 
6-7 years 20-22 kg 6-7 mL 
7-8 years 22-25 kg 7-8 mL 
8-9 years 25-28 kg 8-9 mL 
9-10 years 28-32 kg 9-10 mL 
10-11 years 32-36 kg 10-11 mL 
11-12 years 36-41 kg 11-13 mL 
 
12. If your child weighed 21 kilograms, what dose of Children's Panadol (Elixir 5 - 12 years)  
should you give? Please tick ONE answer only. 
  6 - 7mL 
  7 - 8mL 
  8 - 9mL 
  9 - 10mL 
 
13. If your child is 9 years old what dose of Children's Panadol (Elixir 5 - 12 years) should you give?  
Please tick ONE answer only. 
  6 - 7mL 
  8 - 9 mL 
  10 - 11 mL 
  11 - 13 mL 
 
 
Section B: About you 
 
14. How old are you?___years 
15. What is your sex? ___male  ___female 
16. What country were you born in? 
17. What language do you usually speak at home? 
18. What is the highest level of education you reached? Please tick ONE box. 
  Primary school or Year 6 and below 
  Junior high school or Years 7 to 10 
  Senior high school or Years 11 and 12 
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  TAFE or trade certificate 
  College or University 
19. How confident are you filling out medical forms by yourself? 
  all of the time 
  most of the time 
  some of the time 
  a little of the time 
  none of the time 
 
 
